Neminos Indications/Uses

NEMINOS 100 or 200 injection is indicated for short-term treatment of patients of all ages, including neonates, infants, and children with serious or life-threatening infections caused by susceptible strains of microorganisms in the disease as follows: Urinary tract infections with complication; Septicemia; Skin and skin structure infections; Intra-abdominal infections include peritonitis and intraabdominal abscess; Lower respiratory tract infections.
If not an antibiotic group as the first line, NEMINOS 100 or 200 can be considered for the treatment of serious staphylococcal infections, if Penicillin or other lower-toxic drugs are contraindicated and bacterial susceptibility testing and clinical considerations support their use. Also consider mixed infections caused by susceptible strains of Staphylococcus and gram-negative organisms. NEMINOS 100 or 200 can also be considered as a starting therapy for infections that are suspected or confirmed by gram negative.
In serious infections if the causative organism is unknown, NEMINOS 100 or 200 can be administered as initial treatment concomitantly with penicillin or cephalosporins before the results of the susceptibility test are obtained.
In neonates suspected of sepsis, it is usually given concomitantly with Penicillin. If an anaerobic organism is suspected as a cause, can be given with appropriate antimicrobial therapy. NEMINOS 100 or 200 injection can be used in concomitantly with Carbenicillin or Ticarcillin for the treatment of life-threatening infections caused by Pseudomonas aeruginosa.